Selskabets formål er at drive handel
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 43.9 mio. | 7 mio. | 104.5 mio. | 51.5 mio. | 52 | |
CVR: 83744014
Secondary names: INLOG A/S, BIOFARMA A/S
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Companies in the same industry and area
CVR 26385180
CVR 26543673
CVR 32049478
CVR 36900709
CVR 39720213
The financial health of BIOFARMA LOGISTIK A/S appears to be improving, with a notable increase in profit to 6,951,327 DKK in 2024, up from 6,200,417 DKK in 2023. However, revenue has significantly declined from 293,433,126 DKK in 2022 to 43,948,621 DKK in 2024, indicating potential volatility in sales. The company's equity has strengthened to 51,453,438 DKK, reflecting a solid foundation, though the sharp drop in revenue raises concerns about market position and sustainability. Overall, while profitability has improved, the declining revenue trend suggests the need for strategic focus to stabilize and grow within the competitive pharmaceutical distribution industry.
AI-generated summary
companydata.dk